Pharmaron US Lab Services’ Post

Explore Pharmaron's Cutting-Edge CGT Laboratory Services! At Pharmaron, we offer comprehensive laboratory services to support our partners’ cell and gene therapy needs at every stage. Our advanced CGT technologies include: • In vitro Assays: Expertly developed and validated methods to support a wide range of analytical needs. • In vivo Studies: Harnessing innovative approaches to evaluate the therapeutic potential of CGT products. • Biodistribution & Viral Shedding: Precision bioanalytical methods to assess gene expression and vector presence. • Bioanalysis: Tailored assay development to ensure accurate characterization of CGT products. • Ophthalmology: Specialized ocular disease models to evaluate the efficacy of CGT products in eye disorders. • Safety Assessment: Comprehensive safety evaluations tailored to the unique aspects of CGT products. We adhere to global regulatory requirements (GLP, GCP, GCLP, GMP) and support IND and BLA submissions to FDA, EMA, NMPA, and beyond. Learn more about our services and how we can support your CGT development needs: https://lnkd.in/gg9vMSzY #CGT #Biotechnology #GeneTherapy #CellTherapy #LaboratoryServices

Advance Your Biologics and Cell & Gene Therapy with Pharmaron! From discovery to clinical development, Pharmaron offers comprehensive support for your biologics and CGT programs. Our expert team and cutting-edge facilities are here to bring our partner's innovations to life. • Biologics Laboratory Services: Seamless advancement from discovery to clinical development • Biologics CDMO: Extensive experience in developability assessment and more • Cell & Gene Therapy Laboratory Services: Robust support at all stages, from preclinical to clinical • Gene Therapy CDMO: cGMP biomanufacturing with advanced analytics Discover more about our full suite of services: https://lnkd.in/eQNq8udQ #Biologics #CellAndGeneTherapy #CGT #CDMO #CRO #Biotech #Pharma 

Unlocking the Future of Gene and Cell Therapy with Pharmaron’s CGT Safety Assessment Services At Pharmaron, we’re at the forefront of revolutionizing gene and cell therapy (CGT) with our specialized safety assessment services. Our team brings unparalleled expertise and experience, ensuring that our partners’ CGT products meet the highest safety standards. Our comprehensive CGT Safety Assessment includes: - In vitro and in vivo safety evaluations tailored to your project needs - Advanced genetic toxicology and immunogenicity assessments - Customized study designs to support regulatory submissions - End-to-end support from our highly experienced team members   With Pharmaron’s state-of-the-art cGMP biomanufacturing facility and our commitment to excellence, we are your trusted partner in bringing innovative therapies to market. Connect with us to learn more about how our CGT Safety Assessment services: https://lnkd.in/eA4WSZrm #GeneTherapy #CellTherapy #CGT #SafetyAssessment #Pharmaron #Biomanufacturing #Biotech 

Essential Insights: AAV Immunogenicity Overview Understanding AAV immunogenicity is pivotal for the progress of gene therapies. Our eBook offers a thorough exploration of this vital subject, backed by our deep experience. At Pharmaron, our team, led by study directors with over 20 years in the immunogenicity field, stands ready to assist. We’ve supported 2 out of the 4 FDA-approved CGT products to phase I clinical trials, demonstrating our commitment to success. Discover how our expertise can support your gene therapy initiatives: https://lnkd.in/d3sbTcVy #AAV #Immunogenicity #GeneTherapy #Pharmaron #CGT #FDAApproval

Don't miss this opportunity to learn, connect, and enjoy lunch at the PABC in Doylestown, PA! Lunch & Learn Session: DMPK and Bioanalytical Strategies: Driving discovery through regulatory approval Wednesday, June 12th at 12:00 PM EDT PABC, Room 3100, 38005 Old Easton Rd., Doylestown, PA Click here to register: https://buff.ly/4c6hljd Come hungry for knowledge and lunch as Ragu Ramanathan, PhD, VP DMPK Business Operations and Mitesh Sanghvi, PhD, Sr. Director, Regulated Bioanalysis present DMPK and Bioanalytical strategies that outline the roadmap for driving discovery through regulatory approval. #Pharmaron #DMPK #Bioanalysis #drugdiscovery #roadmap #regulatoryapproval #PABC #PA #Pennsylvania #BucksCounty #biotechnology #lunchandlearn